Reading the Labels on Mutant Mice

Key Takeaways

• 611 mouse samples from 341 strains were genotyped
• Almost 50% of strains did not match their reported names
• Naming rules permit varied congenicity, harming reproducibility
• GQC report standardizes metadata and flags genetic inconsistencies

Pulse Analysis

The laboratory mouse remains the workhorse of biomedical discovery, yet researchers have long relied on nomenclature that assumes a clean, single‑donor genetic background. In practice, the International Committee on Standardized Genetic Nomenclature for Mice (ICSGNM) permits a wide range of genetic variation, leaving scientists uncertain whether a "congenic" strain truly carries only the intended mutation. This ambiguity can compromise experimental outcomes, inflate costs, and raise ethical concerns about animal use.

A recent large‑scale genotyping effort published in Science examined 611 tissue samples representing 341 strains housed at the Mutant Mouse Resource and Research Centers (MMRRC). The results were striking: roughly one‑in‑two strains failed to align with their cataloged names, revealing hidden contributions from secondary or even tertiary donor strains. Such hidden complexity undermines reproducibility, as researchers may attribute phenotypic effects to a presumed genotype that is, in fact, a mosaic. The findings underscore a systemic issue that extends beyond a single repository, threatening the reliability of countless preclinical studies.

In response, the authors introduced the MMRRC Strain GQC (Genotype Quality Control) Report, a uniform template that details the strain’s type, target allele, primary and secondary genetic backgrounds, and an assessment of genome replicability. By flagging problematic elements—such as unintended Cre recombinase or fluorescent protein insertions—the report equips scientists with actionable information before ordering animals. Widespread adoption of this standard could harmonize strain documentation across repositories, reduce wasted animal lives, and restore confidence in mouse‑based research, ultimately accelerating translational breakthroughs.